GWLL Goldenwell Biotech, Inc.

Fundamentals / CIK 0001800373 / USD

Goldenwell Biotech, Inc. reported $55 in revenue and a net loss of $286K for the trailing twelve months ended September 30, 2026 (down 60.4% year over year), with a 21.8% gross margin and a -215356.4% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open GWLL in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

7 fiscal years (2019 to 2025), reported in USD.

$151K$76K$0-$925KFY 2019 Revenue: $0FY 2019 Net Income: -$2.3K2019FY 2020 Revenue: $0FY 2020 Net Income: -$6.3K2020FY 2021 Revenue: $16KFY 2021 Net Income: -$117K2021FY 2022 Revenue: $48KFY 2022 Net Income: -$985K2022FY 2023 Revenue: $1.8KFY 2023 Net Income: -$117K2023FY 2024 Revenue: $139FY 2024 Net Income: -$131K2024FY 2025 Revenue: $55FY 2025 Net Income: -$296K2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $55 $139 $1.8K $48K $16K $0 $0
Cost of Revenue $43 $75 $1.2K $23K $7.6K $0 $0
Gross Profit $12 $64 $666 $25K $8.4K $0 $0
Selling, General & Admin -- -- -- -- $127K $6.4K $2.6K
Total Operating Expenses $113K $123K $116K $1.01M -$127K $6.4K $2.6K
Operating Income -$113K -$123K -$116K -$985K -$118K -$6.4K -$2.6K
Interest Expense $8.4K $8.4K $1.5K -- $0 $0 $0
Income Before Tax -- -$131K -$117K -- -$118K -$6.4K -$2.6K
Income Tax Expense $0 $0 $0 $0 $0 $0 $0
Net Income -$296K -$131K -$117K -$985K -$117K -$6.3K -$2.3K
Basic EPS -- -- -- -- $0.00 $0.00 $0.00
Diluted EPS $0.00 $0.00 $0.00 -- $0.00 $0.00 $0.00
Basic Shares Outstanding -- -- -- -- 91.3M 80.0M 76.2M
Diluted Shares Outstanding 99.0M 99.0M 99.0M -- 91.3M 80.0M 76.2M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $0 $0 $0 $55 $0 $0 $0 $0
Cost of Revenue $0 $0 $0 $43 $0 $0 $0 $0
Gross Profit $0 $0 $0 $12 $0 $0 $0 $0
Total Operating Expenses $29K $35K $31K $23K $26K $28K $36K $25K
Operating Income -$29K -$35K -$31K -$23K -$26K -$28K -$36K -$25K
Interest Expense -- -- $2.1K $2.1K $2.1K $2.1K $2.1K $2.1K
Income Before Tax -- -- -- -- -- -- -$34K --
Income Tax Expense $0 $0 $0 $0 $0 $0 $0 $0
Net Income -$32K -$37K -$18K -$200K -$28K -$30K -$39K -$27K
Diluted EPS -- $0.00 $0.00 $0.00 -- -- $0.00 $0.00
Diluted Shares Outstanding 99.0M 99.0M 99.0M 99.0M 99.0M 99.0M 99.0M 99.0M

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents -- -- $53K $46K $214K $249K $247K
Cash & Short-Term Investments -- -- $53K $46K $214K $249K $247K
Accounts Receivable, Net -- $0 $0 $0 $0 -- --
Inventory $175K $175K $175K $176K $199K $0 --
Total Current Assets -- -- -- -- -- -- $247K
Intangible Assets -- -- -- -- -- $0 $0
Total Non-Current Assets -- -- -- -- -- -- $0
Total Assets $36K $224K $228K $248K $461K $249K $247K
Accounts Payable $0 $0 $0 $0 $111K $0 --
Deferred Revenue (Current) $1.9K $0 -- -- -- -- --
Total Current Liabilities $102K $1.9K -- -- $159K $0 $0
Long-Term Debt -- $174K $46K -- -- -- --
Other Non-Current Liabilities $189K $189K $70K -- -- -- --
Total Non-Current Liabilities $323K $270K -- $20K $0 $0 $0
Total Liabilities $425K $271K $144K $47K $159K $0 $0
Total Debt (incl. Leases) -- $174K $46K $25K $48K -- --
Common Stock $9.9K $9.9K $9.9K $9.9K $9.6K $9.2K $8.0K
Retained Earnings -$1.66M -$1.36M -$1.23M -$1.11M -$126K -$8.6K -$2.3K
Total Stockholders' Equity -$344K -$47K $84K $202K $302K $249K $247K
Total Equity -$344K -$47K $84K $202K $302K $249K $247K

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Accounts Receivable, Net -- -- $0 -- $0 $0 -- $0
Inventory -- $0 $0 $175K $175K $175K $175K $175K
Total Assets $15K $29K $19K $36K $220K $251K $192K $224K
Accounts Payable -- $0 $0 $0 $0 $0 -- $0
Deferred Revenue (Current) -- $0 $100K $1.9K $38K $62K -- $0
Total Current Liabilities $100K $100K $100K $102K $39K $64K -- $1.9K
Long-Term Debt -- -- -- -- -- -- $176K $174K
Other Non-Current Liabilities $189K $189K $189K $189K $189K $189K $189K $189K
Total Non-Current Liabilities $344K $327K $280K $323K $276K $274K -- $270K
Total Liabilities $444K $427K $380K $425K $315K $338K $274K $271K
Total Debt (incl. Leases) -- -- -- -- -- -- $176K $174K
Common Stock $9.9K $9.9K $9.9K $9.9K $9.9K $9.9K $9.9K $9.9K
Retained Earnings -$1.74M -$1.71M -$1.67M -$1.66M -$1.41M -$1.40M -$1.39M -$1.36M
Total Stockholders' Equity -$430K -$398K -$361K -$344K -$144K -$116K -$86K -$47K
Total Equity -$430K -$398K -$361K -$344K -$144K -$116K -$86K -$47K

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$296K -$131K -$117K -$985K $117K -$6.3K -$2.3K
Change in Receivables -- -- $0 $0 $0 -- --
Change in Inventory $43 $75 $1.2K -$23K -$199K $0 --
Change in Payables -- -- -- -$111K $111K $0 --
Operating Cash Flow -$23K -$123K -$113K -$1.07M -$205K -$6.3K -$2.3K
Common Stock Issued -- -- $0 $300 $92K $8.3K $249K
Financing Cash Flow $0 $119K $120K $905K $170K $8.3K $249K
Net Change in Cash -$23K -$3.8K $7.2K -$168K -$35K $2.0K $247K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$32K -$37K -$18K -$200K -$28K -$30K -$39K -$27K
Change in Receivables -- $0 $0 -- $0 $0 $0 --
Change in Inventory $0 $0 $175K $43 $0 $0 $0 -$73
Change in Payables -- $0 $0 -- $0 $0 $0 --
Operating Cash Flow -$25K -$47K -$13K -$19K -$31K $59K -$32K -$25K
Common Stock Issued -- $0 $0 -- $0 $0 $0 --
Financing Cash Flow $15K $45K $0 $0 $0 $0 $0 $70K
Net Change in Cash -$10K -$2.3K -$13K -$19K -$31K $59K -$32K $45K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin 21.8% 46.0% 36.3% 52.7% 52.5% -- --
Operating Margin -206047.3% -88559.7% -6308.6% -2060.9% -740.7% -- --
Net Profit Margin -539038.2% -94602.9% -6392.2% -2060.9% -732.6% -- --
Return on Equity (ROE) -- -- -139.3% -488.6% -38.8% -2.5% -0.9%
Return on Assets (ROA) -820.8% -58.7% -51.5% -396.6% -25.4% -2.5% -0.9%
Quick Ratio -- -- -- -- 1.34x -- --
Debt to Equity -- -- 0.55x 0.13x 0.16x -- --
Revenue Growth (YoY) -60.4% -92.4% -96.2% +199.4% -- -- --
Gross Profit Growth (YoY) -81.2% -90.4% -97.4% +200.3% -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Gross Margin 21.8% 21.8% 21.8% 21.8% -- -- 50.4% 50.4%
Operating Margin -215356.4% -208729.1% -196772.7% -206047.3% -- -- -93937.4% -88556.1%
Net Profit Margin -519567.3% -512940.0% -500983.6% -539038.2% -- -- 5033.8% 55043.2%
Return on Assets (ROA) -1965.6% -973.6% -1469.2% -820.8% -56.3% -29.1% 3.6% 34.1%
Revenue Growth (YoY) -- -- -- -- -- -100.0% -- -100.0%
Gross Profit Growth (YoY) -- -- -- -- -- -100.0% -- -100.0%
Net Income Growth (YoY) -- -- -- -- -220.9% -160.7% -224.4% --
Operating Cash Flow Growth (YoY) -- -179.6% -- -- -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001800373) · from September 30, 2019 Data through September 30, 2026 · synced Nov 20, 2026, 05:52 UTC · Open in terminal